Skip to Content

W 907 (Ranitidine 300 mg)

Pill imprint W 907 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 300 mg W 907
Discount Card Promo
Ranitidine hydrochloride
W 907
300 mg
16.00 mm
Elliptical / Oval
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium silicate
silicon dioxide colloidal
magnesium stearate
castor oil
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63304-0839 Ranbaxy Pharmaceuticals Inc.
54569-4508 A-S Medication Solutions, LLC (repackager)
21695-0110 Rebel Distributors Corp (repackager)
66336-0887 Dispensing Solutions Inc. (repackager)
33261-0202 Aidarex Pharmacuticals, LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.